Clinical Trial Update: Dendritic Cell Based Therapy of Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of a dendritic cell based therapy for advanced renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Dendritic cell-based therapy

Snippet

Sponsor: Inge Marie Svane | Conditions: Advanced Renal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED